Volume | 2,900 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Zivo Bioscience Inc (PK) | ZIVOW | OTCMarkets | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.95 | 1.90 | 1.95 | 1.9099 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
---|---|---|---|---|
3 | 2,900 | 1.9021 | 5,516 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
08:42:27 | 2,700 | 1.90 | USD |
Zivo Bioscience Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.48M | 428.53M | - | 28k | -7.78M | -4.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Zivo Bioscience (PK)
Date | Time | Source | Heading |
---|---|---|---|
1/03/2025 | 15:27 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
1/03/2025 | 15:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
1/03/2025 | 15:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
11/15/2024 | 05:30 | Edgar (US Regulatory) | Form 8-K - Current report |
11/14/2024 | 15:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/18/2024 | 16:26 | Edgar (US Regulatory) | Form 8-K - Current report |
10/17/2024 | 18:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/16/2024 | 15:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/01/2024 | 15:13 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
10/01/2024 | 13:57 | Edgar (US Regulatory) | Form SC 13D/A - General Statement of Acquisition of.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ZIVOW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Zivo Bioscience, Inc. is a Michigan-based biotech company engaged: 1) in the investigation of the health benefits of bioactive compounds derived from its proprietary algal cultures, and the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as potential candidates for future medicinal and pharmaceutical applications in humans and animals, focused on autoimmune modulation and 2) developing, manufacturing, marketing, and selling tests that the Company believes will allow people to optimize their health and identify future health risks. |